Profile
M.H. Carnegie & Co. is a private equity and venture capital firm based in Moore Park, New South Wales, Australia, founded in 2010 by Mark Carnegie. The firm operates with a small team of around 10 professionals, including three partners. M.H. Carnegie & Co. distinguishes itself by aligning its economic interests with those of its clients through co-investment strategies, ensuring that their financial goals are closely aligned.
The firm invests across a broad range of asset classes, including venture capital, private equity, real estate, and debt. It focuses on sectors such as life sciences, travel and hospitality, and therapeutic devices. M.H. Carnegie & Co. primarily invests in companies based in Australia and the United States. The firm does not specify a typical check size but emphasizes a flexible investment approach tailored to client needs.
Notable investments by M.H. Carnegie & Co. include Cardiac Dimensions - therapeutic devices, EBR Systems - therapeutic devices, Simplify Medical - therapeutic devices, Lonsec - financial services, and DigiBuild - business productivity software. These investments highlight the firm's diverse portfolio and its focus on sectors with significant growth potential.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.